Research progress in the radioprotective effect of superoxide dismutase

Drug Discoveries & Therapeutics

Volumn 6, Issue 4, 2011, Pages 169-177

  Huang, Xiaojing ^a,b   Song, Chunxia ^a,b,c   Zhong, Chuanqing ^a,b,d   Wang, Fengshan ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d SHANDONG JIANZHU UNIVERSITY   (China)

Author keywords

radiation; radioprotection; reactive oxygen species; Superoxide dismutase

Indexed keywords

EID: 85008743350     PISSN: 18817831     EISSN: 1881784X     Source Type: Journal    
DOI: 10.5582/ddt.2012.v6.4.169     Document Type: Article

References (68)

1. Radiological Protection Institute of Ireland. Your radiation exposure: Sources of radiation. http://www.rpii. ie/Your-Health/ Your-radiation-exposure.aspx (accessed October 16, 2011).
2. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist. 2010; 15:360371.
3. Christodouleas JP, Forrest RD, Ainsley CG, Tochner Z, Hahn SM, Glatstein E. Short-term and long-term health risk of nuclear-power-plant accidents. N Engl J Med. 2011; 364:2334-2341.
4. Brown DQ, Pittock JW 3rd, Rubinstein JS. Early results of the screening program for radioprotectors. Int J Radiat Oncol Biol Phys. 1982; 8:565-570.
5. Cassatt DR, Fazenbaker CA, Bachy CM, Hanson MS. Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy. Semin Radiat Oncol. 2002; 12:97-102.
6. Koukourakis MI, Kyrias G, Kakolyris S, Kouroussis C, Frangiadaki C, Giatromanolaki A, Retalis G, Georgoulias V. Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized phase II study. J Clin Oncol. 2000; 18:2226-2233.
7. Andreassen CN, Grau C, Lindegaard JC. Chemical radioprotection: A critical review of amifostine as a cytoprotector in radiotherapy. Semin Radiat Oncol. 2003; 13:62-72.
8. Wasserman TH, Brizel DM. The role of amifostine as a radioprotector. Oncology (Williston Park). 2001; 15: 1349-1354; discussion 1357-1360.
9. Antonadou D, Throuvalas N, Petridis A, Bolanos N, Sagriotis A, Synodinou M. Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2003; 57:402-408.
10. Holley AK, Xu Y, St Clair DK, St Clair WH. ReIB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Ann N Y Acad Sci. 2010; 1201:129-136.
11. Murley JS, Kataoka Y, Miller RC, Li JJ, Woloschak G, Grdina DJ. SOD2-mediated effects induced by WR1065 and low-dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells. Radiat Res. 2011; 175:57-65.
12. Murley JS, Kataoka Y, Baker KL, Diamond AM, Morgan WF, Grdina DJ. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha. Radiat Res. 2007; 167:465-474.
13. Zhang C, Ni J, Gao F, Sun D, Zhou C, Cheng Y, Cai J, Li B. The mechanism for the ameliorative effect of CpG-oligodeoxynucleotides on bone marrow hemopoiesis radiation injury. Basic Clin Pharmacol Toxicol. 2011; 109:11-16.
14. Afonso V, Champy R, Mitrovic D, Collin P, Lomri A. Reactive oxygen species and superoxide dismutases: Role in joint diseases. Joint Bone Spine. 2007; 74:324329.
15. Sugamura K, Keaney JF Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 2011; 51:978-992.
16. Silva JP, Coutinho OP. Free radicals in the regulation of damage and cell death-basic mechanisms and prevention. Drug Discov Ther. 2010; 4:144-167.
17. Schäfer M, Werner S. Oxidative stress in normal and impaired wound repair. Pharmacol Res. 2008; 58:165171.
18. Sonntag CV. The Chemical Basis of Radiation Biology. Taylor & Francis, London, UK, 1987; pp. 31-56.
19. Greenberger JS, Epperly MW, Gretton J, Jefferson M, Nie S, Bernarding M, Kagan V, Guo HL. Radioprotective gene therapy. Curr Gene Ther. 2003; 3:183-195.
20. Greenberger JS, Epperly MW. Radioprotective antioxidant gene therapy: Potential mechanisms of action. Gene Ther Mol Biol. 2004; 8:31-44.
21. Greenberger JS, Epperly MW. Antioxidant therapeutic approaches toward amelioration of the pulmonary pathophysiological damaging effects of ionizing irradiatioin. Curr Respir Med Rev. 2007; 3:29-39.
22. Riley PA. Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 1994; 65:27-33.
23. Hall EJ, Giaccia AJ. Radiobiology for the radiologist. Lippi cott Williams & Wilkins, Philadelphia, USA, 2000.
24. Lavi R, Shainberg A, Shneyvays V, Hochauser E, Isaac A, Zinman T, Friedmann H, Lubart R. Detailed analysis of reactive oxygen species induced by visible light in various cell types. Lasers Surg Med. 2010; 42:473-480.
25. McCord JM, Fridovich I. Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein). J Biol Chem. 1969; 244:6049-6055.
26. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Nati Acad Sci U S A. 1982; 79:7634-7638.
27. Weisiger RA, Fridovich I. Mitochrondrial superoxide dismutase. Site of synthesis and intramitochondrial localization. J Biol Chem. 1973; 248:4793-4796.
28. Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med. 2003; 167:1600-1619.
29. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006; 52:601-623.
30. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39:44-84.
31. Bentzen SM. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer. 2006; 6:702-713.
32. Yan S, Brown SL, Kolozsvary A, Freytag SO, Lu M, Kim JH. Mitigation of radiation-induced skin injury by AAV2-mediated MnSOD gene therapy. J Gene Med. 2008; 10:1012-1018.
33. Williams JP, Brown SL, Georges G E, et al. Animal models for medical countermeasures to radiation exposure. Radiat Res. 2010; 173:557-578.
34. Petkau A, Kelly K, Chelack WS, Barefoot C. Protective effect of superoxide dismutase on erythrocytes of X-irradiated mice. Biochem Biophys Res Commun. 1976; 70:452-458.
35. Petkau A, Chelack WS, Pleskach SD. Protection of superoxide dismutase of white blood cells in X-irradiated mice. Life Sci. 1978; 22:867-882.
36. Eastgate J, Moreb J, Nick HS, Suzuki K, Taniguchi N, Zucali JR. A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-1. Blood. 1993; 81:639-646.
37. Liu J, Wang X, Wang F, Teng L, Cao J. Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro. Biomed Pharmacother. 2009; 63:484-491.
38. Graves PR, Siddiqui F, Anscher MS, Movsas B. Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol. 2010; 20:201-207.
39. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 1995; 33:99-109.
40. Machtay M, Scherpereel A, Santiago J, Lee J, McDonough J, Kinniry P, Arguiri E, Shuvaev VV, Sun J, Cengel K, Solomides CC, Christofidou-Solomidou M. Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse. Radiother Oncol. 2006; 81:196-205.
41. Barasch A, Epstein JB. Management of cancer therapy-induced oral mucositis. Dermatol Ther. 2011; 24:424-431.
42. Tai Y, Inoue H, Sakurai T, Yamada H, Morito M, Ide F, Mishima K, Saito I. Protective effect of lecithinized SOD on reactive oxygen species-induced xerostomia. Radiat Res. 2009; 172:331-338.
43. Nagler RM, Reznick AZ, Slavin S, Nagler A. Partial protection of rat parotid glands from irradiation-induced hyposalivation by manganese superoxide dismutase. Arch Oral Biol. 2000; 45:741-747.
44. Stickle RL, Epperly MW, Klein E, Bray JA, Greenberger JS. Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene. Radiat Oncol Investig. 1999; 7:204-217.
45. Bernhard EJ, Maity A, Muschel RJ, McKenna WG. Effects of ionizing radiation on cell cycle progression. A review. Radiat Environ Biophys. 1995; 34:79-83.
46. Gao Z, Sarsour EH, Kalen AL, Li L, Kumar MG, Goswami PC. Late ROS accumulation and radiosensitivity in SOD1-overexpressing human glioma cells. Free Radic Biol Med. 2008; 45:1501-1509.
47. Epperly MW, Carpenter M, Agarwal A, Mitra P, Nie S, Greenberger JS, Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis. In Vivo. 2004; 18:401-410.
48. Fernet M, Megnin-Chanet F, Hall J, Favaudon V. Control of the G2/M checkpoints after exposure to low doses of ionizing radiation: implications for hyper-radiosensitivity. DNA Repair (Amst). 2010; 9:48-57.
49. Kalen AL, Sarsour EH, Venkataraman S, Goswami PC. Mn-superoxide dismutase overexpression enhances G2 accumulation and radioresistance in human oral squamous carcinoma cells. Antioxid Redox Signal. 2006; 8:1273-1281.
50. Giebel B, Bruns I. Self-renewal versus differentiation in hematopoietic stem and progenitor cells: A focus on asymmetric cell divisions. Curr Stem Cell Res Ther. 2008; 3:9-16.
51. Niu Y, Shen H, Epperly M, Zhang X, Nie S, Cao S, Greenberger JS, Protection of esophageal multi-lineage progenitors of squamous epithelium (stem cells) from ionizing irradiation by manganese superoxide dismutase- plasmid/liposome (MnSOD-PL) gene therapy. In Vivo. 2005; 19:965-974.
52. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med. 2005; 353:46-57.
53. Petkau A, Chelack WS. Radioprotective effect of superoxide dismutase on model phospholipid membranes. Biochim Biophys Acta. 1976; 433:445-456.
54. Epperly MW, Tyurina YY, Nie S, Niu YY, Zhang X, Kagan V, Greenberger JS. MnSOD-plasmid liposome gene therapy decreases ionizing irradiation-induced lipid peroxidation of the esophagus. In Vivo. 2005; 19:9971004.
55. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem. 1999; 264:687701.
56. Epperly MW, Melendez JA, Zhang X, Nie S, Pearce L, Peterson J, Franicola D, Dixon T, Greenberger BA, Komanduri P, Wang H, Greenberger JS. Mitochondrial targeting of a catalase transgene product by plasmid liposomes increases radioresistance in vitro and in vivo. Radiat Res. 2009; 171:588-595.
57. Gorman S, Tosetto M, Lyng F, Howe O, Sheahan K, O'Donoghue D, Hyland J, Mulcahy H, O'Sullivan J. Radiation and chemotherapy bystander effects induce early genomic instability events: Telomere shortening and bridge formation coupled with mitochondrial dysfunction. Mutat Res. 2009; 669:131-138.
58. Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: From mechanistic understanding to cancer treatment. DNA Repair (Amst). 2007; 6:923-935.
59. Wiktor-Brown DM, Kwon HS, Nam YS, So PT, Engelward BP. Integrated one- and two-photon imaging platform reveals clonal expansion as a major driver of mutation load. Proc Nati Acad Sci U S A. 2008; 105:10314-10319.
60. Harper JV, Reynolds P, Leatherbarrow EL, Botchway SW, Parker AW, O'Neill P. Induction of persistent double strand breaks following multiphoton irradiation of cycling and G1-arrested mammalian cells-replication-induced double strand breaks. Photochem Photobiol. 2008; 84:1506-1514.
61. Natarajan AT, Palitti F. DNA repair and chromosomal alterations. Mutat Res. 2008; 657:3-7.
62. Niu Y, Wang H, Wiktor-Brown D, Rugo R, Shen H, Huq MS, Engelward B, Epperly M, Greenberger JS. Irradiated esophageal cells are protected from radiation-induced recombination by MnSOD gene therapy. Radiat Res. 2010; 173:453-461.
63. Liu JF, Wang X, Tan HN, Liu H, Wang YG, Chen RQ, Cao JC, Wang FS. Effect of heparin-superoxide dismutase on γ-radiation induced DNA damage in vitro and in vivo. Drug Discov Ther. 2010; 4:355-361.
64. Nielsen OS, Overgaard J, Overgaard M, Steenholdt S, Jakobsen A, Sell A. Orgotein in radiation treatment of bladder cancer. A report on allergic reactions and lack of radioprotective effect. Acta Oncol. 1987; 26:101-104.
65. Hosseinimehr SJ. Trends in the development of raidioprotective agents. Drug Discov Today. 2007; 12:794-805.
66. Bafana A, Dutt S, Kumar A, Kumar S, Ahuja PS, The basic and applied aspects of superoxide dismutase. J Mol Catal B Enzym. 2011; 68:129-138.
67. Liu J, Zhao T, Tan H, Cheng Y, Cao J, Wang F. Pharmacokinetic analysis of in vivo disposition of heparin-superoxide dismutase. Biomed Pharmacother. 2010; 64:686-691.
68. Zhang HW, Wang FS, Shao W, Zheng XL, Qi JZ, Cao JC, Zhang TM. Characterization and stability investigation of Cu, Zn-superoxide dismutase covalently modified by low molecular weight heparin. Biochemistry (Mosc). 2006; 71 (Suppl. 1):S96-S100, 5. 69. Thompson JS, Chu Y, Glass J, Tapp AA, Brown SA. The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiation. Free Radic Res. 2010; 44:529-540.